Digital AI could save the NHS, but risks sharing private patient dat... It’s becoming increasingly evident that simply anonymising and de-identifying sensitive data is no panacea for big tech’s data privacy problem.
Digital Defending against third-party security risks in pharma compa... Even if a pharmaceutical company has a robust cybersecurity posture and a history unmarred by data breaches, it is still vulnerable to security incidents.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
Digital Boosting trust in AI: The essential foundation for breakthro... The use of artificial intelligence (AI) in healthcare is growing rapidly and already providing patients with better care and support.
Digital How to conduct a cybersecurity audit on your pharma supply c... Drug manufacturers, wholesale distributors and pharmacies stepped up during the COVID-19 pandemic to preserve supply chain integrity.
Digital Safeguarding patient data: Four steps to consider when asses... A recent cyberattack on major hospitals in London has once again called into question the security of patient data in the UK.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.